NCCN guidelines for the management of ovarian cancer, as well as fallopian and primary peritoneal cancers, specify that patients diagnosed with those diseases should have germline and somatic testing. But what does this even mean? And how is that different from genetic or genomic testing? OCRA offers free genetic testing for those who qualify. Fill … Continued
In exciting treatment news, the Food and Drug Administration (FDA) has granted accelerated approval to mirvetuximab soravtansine-gynx (trade name Elahere, made by Immunogen, Inc.), for adults with folate receptor alpha (FRa) positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have undergone one to three earlier systemic treatment regimens. The FDA also approved … Continued
Many ovarian cancer patients and survivors wonder what the ideal diet for ovarian cancer may be. In a nutshell – there is no simple answer. In this article, adapted from a presentation given by expert Cara Anselmo, Clinical Dietitian-Nutritionist at Memorial Sloan Kettering Cancer Center at OCRA’s 2022 Ovarian Cancer National Conference, you will learn why no … Continued
Dear Friends, I hope this finds you well. Whether you’re celebrating with loved ones today or holding them in your thoughts, my wish for you is that you’re feeling comfort and joy. On this day of gratitude, I don’t have to look far to find reasons to be thankful. Every day, I’m struck by the … Continued
“I don’t believe we can maximize our impact on ovarian cancer without embracing opportunities in other gynecologic cancers.” Dr. David Huntsman David Huntsman, MD, FRCPC, FCCMG, understands the field of ovarian cancer research. He is the Scientific Director and Co-Founder of OVCARE, which is now part of British Columbia’s Gynecologic Cancer Initiative. He works with … Continued
This past year, nearly 20,000 women had their lives turned upside down with an ovarian cancer diagnosis. Ovarian cancer can be devastating to patients and their families – but with your help, there is hope. Ovarian Cancer Research Alliance is the largest charity in the world fighting ovarian cancer from every angle – in the … Continued
As we approach the time of year when we reflect on all that we are thankful for, we at OCRA are grateful for you — our incredible community — who support us in this joined fight and inspire us every day to keep pushing forward. Research Advocacy Patient Support Events Ways to Give The holiday gift giving season is nearly upon … Continued
Personal stories have power. And simply by sharing your story on social media, you can raise important funds to support OCRA’s fight against ovarian cancer. All you have to do is post on social media on Tuesday, November 29th describing what a donation to OCRA means to you. It’s that simple! An angel donor will … Continued
After a whirlwind September that saw many of you rallying your communities, spreading the word, and making a difference, we’re welcoming autumn, fall colors, and the chance to share some great new write-ups about the projects and programs your efforts are supporting. Read on! Research Advocacy Patient Support Events Ways to Give
Ie-Ming Shih, MD, PhD is on a quest to better understand the human condition. He is a pathologist who studies human tissue to learn more about the origins of ovarian cancer; a Distinguished Professor (Endowed Chair) of Gynecologic Pathology who directs that research program at the Johns Hopkins University School of Medicine; the co-director of … Continued
OCRA is now accepting nominations for the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research. The deadline to submit a nomination is 5:00pm ET on October 31, 2022. About the Rosalind Franklin Prize The Rosalind Franklin Prize for Excellence in Ovarian Cancer Research is a $10,000 annual prize awarded to an individual in recognition of their … Continued
When a person is diagnosed with ovarian cancer, their whole world is often turned upside down. As they work to overcome that diagnosis, the last thing they should be worrying about is whether they can afford to pay for their treatment. Unfortunately, many patients are faced with this dilemma, with some drugs that cost well … Continued
Get email updates about research news, action alerts, and ways to join the fight.
